Attached files

file filename
10-Q - FORM 10-Q - My Size, Inc.c21778e10vq.htm
EX-31.1 - EXHIBIT 31.1 - My Size, Inc.c21778exv31w1.htm
EX-10.3 - EXHIBIT 10.3 - My Size, Inc.c21778exv10w3.htm
EX-32.1 - EXHIBIT 32.1 - My Size, Inc.c21778exv32w1.htm
EX-10.2 - EXHIBIT 10.2 - My Size, Inc.c21778exv10w2.htm
EX-10.1 - EXHIBIT 10.1 - My Size, Inc.c21778exv10w1.htm
EX-31.2 - EXHIBIT 31.2 - My Size, Inc.c21778exv31w2.htm
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of TopSpin Medical, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Uri Ben-Or, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
             
    TOPSPIN MEDICAL, INC.    
 
           
Date: August 22, 2011
  By:   /s/ Uri Ben-Or
 
Uri Ben-Or
   
 
      Chief Financial Officer    
 
      (Principal Financial Officer)    
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.